MarketResearchFuture.com adds “Human Rotavirus Vaccine Market -2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.
The report titled “Human Rotavirus Vaccine Market -Forecast to 2023″ is a direct appreciation by Market Research Future of the market potential of the Human Rotavirus Vaccine Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market! The global human rotavirus vaccine market is expected to reach US$ 12.3 billion by 2023, and the market is projected to grow at a CAGR of ~ 11.2 % during the forecast period 2017-2023.
Regional Analysis of Global Human Rotavirus Vaccine Market:
The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new technology in the US drives the global human rotavirus vaccine market. Also, concentration of major research companies and vaccine research sector in the developed countries of this region is adding fuel to the market growth.
Europe is the second largest market in the world due to high income and healthcare penetration.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.
Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Human rotavirus vaccine Market” Research Report – Forecast till 2023.
Major Players in the Human Rotavirus Vaccine Market:
Key players profiled in the report are Bharat Biotech, Merck & Co., Inc., GlaxoSmithKline plc, Sanofi and others.
Market Scenario of the Human Rotavirus Vaccine Market:
Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Rotavirus vaccine is administered by mouth and requires two or three doses which are given starting around six weeks of age. The vaccine first became available in the United States in 2006. Rotavirus is a double-stranded RNA virus of the family Reoviridae and is transmitted by the faecal-oral route. It infects the cell lining of the small intestine and causes gastroenteritis. According to National Center for Biotechnology Information, rotavirus related diarrhoea is responsible for killing about 600,000 children in 2015, with more than 80% of all rotavirus-related deaths occurring in in south Asia and sub-Saharan Africa. Rotavirus-related deaths represent approximately 5% of all deaths in children younger than 5 years of age worldwide. Almost every child in the world is infected with rotavirus at least once by the age of five. The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs. The vaccines is responsible to prevent 15 to 34% of severe diarrhoea in the developing world and 37 to 96% of severe diarrhoea in the developed world. According to World Health Organization (WHO) in Mexico a decline of up to 50% in diarrhoeal deaths in children less than 5 years of age was attributed directly to the use of the vaccine.
Product development is the most attractive strategy for the human rotavirus vaccine industry. Latest vaccines have withstood historic safety profiles because intussusception was a complication of the first rotavirus vaccine, RotaShield. Cost effective production remains another challenge as human rotavirus vaccines are many times expensive per dose than the cheapest traditional treatment.
TRY SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/4171 .
Segmentation of Global Human Rotavirus Vaccine Market:
The global Human rotavirus vaccine market has been segmented on the basis of type and end users.
Based on type, the market has been segmented as Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb and others.
Based on the end users, the market has been segmented as hospitals & clinics, academic and research and others.
Major TOC of Human Rotavirus Vaccine Market:
Chapter 1 Introduction
Chapter 2 Research Methodology
Chapter 3 Market Dynamics
Chapter 4 Market Factor Analysis
Chapter 5 Global Human Rotavirus Vaccine Market, By Type
Chapter 6 Global Human Rotavirus Vaccine Market, By End Users
Chapter 7 Global Human Rotavirus Vaccine Market, By Region
Chapter 8 Competitive Landscape
Chapter 9 Company Profile
Chapter 10 Conclusion
Chapter 11 Appendix
…CONTINUED
AWAIL DISCOUNT @ https://www.marketresearchfuture.com/check-discount/4171 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/enquiry/4171